Targeting ATXN2 Using Antisense Oligonucleotides as a Treatment for Spinocerebellar Ataxia Type 2 (SCA2)

被引:0
|
作者
Scoles, Daniel [4 ]
Schneider, Matthew [4 ]
Meera, Pratap [3 ]
Figueroa, Karla [4 ]
Hung, Gene [1 ]
Rigo, Frank [2 ]
Bennett, Frank [2 ]
Otis, Thomas [3 ]
Pulst, Stefan [4 ]
机构
[1] ISIS Pharmaceut, 2280 Faraday Ave, Carlsbad, CA 92008 USA
[2] Isis Pharmaceut Inc, Carlsbad, CA USA
[3] Univ Calif Los Angeles, Los Angeles, CA USA
[4] Univ Utah, Salt Lake City, UT USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
S30.007
引用
收藏
页数:2
相关论文
共 50 条
  • [21] An Electrophysiological Study of Visual Processing in Spinocerebellar Ataxia Type 2 (SCA2)
    Jan Kremlacek
    Martin Valis
    Jiri Masopust
    Ales Urban
    Alena Zumrova
    Radomir Talab
    Miroslav Kuba
    Zuzana Kubova
    Jana Langrova
    The Cerebellum, 2011, 10 : 32 - 42
  • [22] Involvement of the cranial nerves and their nuclei in spinocerebellar ataxia type 2 (SCA2)
    Gierga, K
    Bürk, K
    Bauer, M
    Diaz, GO
    Auburger, G
    Schultz, C
    Vuksic, M
    Schöls, L
    de Vos, RAI
    Braak, H
    Deller, T
    Rüb, U
    ACTA NEUROPATHOLOGICA, 2005, 109 (06) : 617 - 631
  • [23] An Electrophysiological Study of Visual Processing in Spinocerebellar Ataxia Type 2 (SCA2)
    Kremlacek, Jan
    Valis, Martin
    Masopust, Jiri
    Urban, Ales
    Zumrova, Alena
    Talab, Radomir
    Kuba, Miroslav
    Kubova, Zuzana
    Langrova, Jana
    CEREBELLUM, 2011, 10 (01): : 32 - 42
  • [24] CRISPR-Cas9 Gene Editing Strategies of ATXN2 for the Treatment of Spinocerebellar Ataxia Type 2
    Simpson, Bryan P.
    Keiser, Megan S.
    Monteys, Alex Mas
    Davidson, Beverly L.
    MOLECULAR THERAPY, 2019, 27 (04) : 112 - 112
  • [25] Spinocerebellar Ataxia Type 2: CAG Repeat Expansion Size of ATXN2 in the Pediatric Population
    Stanley, Christine M.
    Hill, David
    Casey, Kristie
    Bishop, Crystal
    Moore, Rebecca
    Ito, Masamichi
    NEUROLOGY, 2011, 76 (09) : A350 - A350
  • [26] Pathoanatomy of Cerebellar Degeneration in Spinocerebellar Ataxia Type 2 (SCA2) and Type 3 (SCA3)
    W. Scherzed
    E. R. Brunt
    H. Heinsen
    R. A. de Vos
    K. Seidel
    K. Bürk
    L. Schöls
    G. Auburger
    D. Del Turco
    T. Deller
    H. W. Korf
    W. F. den Dunnen
    U. Rüb
    The Cerebellum, 2012, 11 : 749 - 760
  • [27] Pathoanatomy of Cerebellar Degeneration in Spinocerebellar Ataxia Type 2 (SCA2) and Type 3 (SCA3)
    Scherzed, W.
    Brunt, E. R.
    Heinsen, H.
    de Vos, R. A.
    Seidel, K.
    Buerk, K.
    Schoels, L.
    Auburger, G.
    Del Turco, D.
    Deller, T.
    Korf, H. W.
    den Dunnen, W. F.
    Rueb, U.
    CEREBELLUM, 2012, 11 (03): : 749 - 760
  • [28] Thalamic involvement in a spinocerebellar ataxia type 2 (SCA2) and a spinocerebellar ataxia type 3 (SCA3) patient, and its clinical relevance
    Rüb, U
    Del Turco, D
    Del Tredici, K
    de Vos, RAI
    Brunt, ER
    Reifenberger, G
    Seifried, C
    Schultz, C
    Auburger, G
    Braak, H
    BRAIN, 2003, 126 : 2257 - 2272
  • [29] Involvement of the cholinergic basal forebrain nuclei in spinocerebellar ataxia type 2 (SCA2)
    Rueb, U.
    Farrag, K.
    Seidel, K.
    Brunt, E. R.
    Heinsen, H.
    Buerk, K.
    Melegh, B.
    von Gall, C.
    Auburger, G.
    Bohl, J.
    Korf, H. W.
    Hoche, F.
    den Dunnen, W.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2013, 39 (06) : 634 - 643
  • [30] Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2)
    Furtado, S
    Payami, H
    Lockhart, PJ
    Hanson, M
    Nutt, JG
    Singleton, AA
    Singleton, A
    Bower, J
    Utti, RJ
    Bird, TD
    de la Fuente-Femandez, R
    Tsuboi, Y
    Klimek, ML
    Suchowersky, O
    Hardy, J
    Calne, DB
    Wszolek, ZK
    Farrer, M
    Gwinn-Hardy, K
    Stoessl, AJ
    MOVEMENT DISORDERS, 2004, 19 (06) : 622 - 629